New World Advisors’s DexCom DXCM Stock Holding History

New World Advisors’s Portfolio DXCM Stock Details DXCM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-200	Closed	-$6K	–	47
2019 Q1	$6K	Buy	+200	New	+$7.03K	﹤0.01%	99

Other funds holding DXCM

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

New World Advisors's DXCM Position: Q2 2019 in Review

New World Advisors sold out of DexCom (DXCM) in Q2 2019, closing a stake of 200 shares — an estimated $6K sold.

New World Advisors first reported a position in DXCM in Q1 2019 and held it in 1 quarter. The position peaked at $6K in Q1 2019. 418 funds tracked by Wall St. Rank hold DXCM as of Q2 2019.

New World Advisors reported no remaining DexCom position as of Q2 2019 after selling out during the quarter.
New World Advisors sold 200 DexCom shares in Q2 2019, an estimated $6K.
New World Advisors first reported a position in DexCom in Q1 2019 and held it in 1 quarter.
New World Advisors's DexCom position peaked at $6K in Q1 2019.
418 funds tracked by Wall St. Rank held DexCom as of Q2 2019.

Based on New World Advisors's 13F filing for Q2 2019, filed 14 Aug 2019.